On Sept. 24, the 2019 Halifax Benefits Summit featured insightful sessions on benefits, health and wellness and drug plan trends.
Here’s what you missed!
Integrating data to show plan sponsors a full picture of claims patterns
Group insurers are considering data more intelligently to develop products, services and plan designs that are optimal for plan sponsors, but also engage members by using their own personal health and transactional data to involve them in their own well-being. Read more
The value of private drug plans from a Canadian and global context
When it comes to health-care spending in Canada, there isn’t a lot of variance between provinces, according to Joe Farago, executive director of private payers and investment at Innovative Medicines Canada. Read more
How employers, health-care policies can support employees with irritable bowel disease
With around 270,000 individuals currently affected by irritable bowel disease, Canada has the highest prevalence in the world, according to Mina Mawani, president and chief executive officer of Crohn’s and Colitis Canada, during a session at Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24. Read more
A look at the newest innovative medications for diabetes management
As the prevalence of diabetes continues to rise, so do the increases in cost, according to Adam Hotchkiss, medical science liaison at Novo Nordisk Canada, during Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24. Read more
Managing diabetes in the new era of glucose monitoring technology
Since diabetes is a progressive disease, it’s important to get treatment in the middle, according to Dr. Thomas Ransom, endocrinologist at the Nova Scotia Health Authority, during Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24. Read more
Policies around transitioning to biosimilars in Europe, the U.S. and Canada
Sixty per cent of all prescriptions in Canada are paid for by employer-provided drug plans and some have life-time limits for biologic reimbursement. Read more
What role can pharmacists play in health-care access, improved outcomes?
Canada’s health-care system isn’t working or sustainable, and the gap between private and publicly funded services deserves our attention, according to Rose Dipchand, regional manager of professional affairs at Pharmasave Atlantic, during Benefits Canada’s 2019 Halifax Benefits Summit on Sept. 24. Read more
Measuring quality of health-care providers touted as opportunity for change
The requirement to measure and report on the quality of the health-care services delivered by providers is growing, alongside the redefined nature of the relationship between payers and health-care providers, such as pharmacy, said Ned Pojskic, leader of pharmacy and health provider relations at Green Shield Canada. Read more
Find out about more Benefits Canada‘s events.